Imiquimod for high-risk HPV cervical lesions
Treatments studied
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial tests if imiquimod cream can help clear high-grade cervical lesions caused by high-risk HPV. It may be an option for people who want to avoid surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 45 years old
- You have high-risk HPV and a high-grade cervical lesion (CIN 3) confirmed by biopsy at Barretos Cancer Hospital
- You live within 300 km of Barretos, São Paulo
- You are not pregnant or breastfeeding
- You have not been vaccinated for HPV
- You have not used antibiotics in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
This trial tests a combination of an HPV vaccine, an immune cream (imiquimod), and a diabetes drug (metformin) together with standard chemoradiation. The goal is to see if this mix helps treat advanced cervical, vaginal, or vulvar cancers better than standard care alone.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This trial tests a cream called imiquimod for people who have been diagnosed with oral dysplasia, a precancerous condition in the mouth. It is an option for those who cannot or choose not to have surgery or laser treatment.
This study tests a topical gel made from curcumin (a compound in turmeric) to see if it can help clear abnormal cervical cells caused by HPV. It may be an option for women with low-grade changes or who have recently had high-grade changes treated.
This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.
Hear when a new HSIL, High Grade Squamous Intraepithelial Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.